布地奈德与特布他林吸入治疗毛细支气管炎疗效观察被引量：1

下载PDF

导出

摘要目的观察布地奈德与特布他林联合吸入治疗毛细支气管炎的临床疗效。方法将106例毛细支气管炎患儿随机分为治疗组(58例)和对照组(48例),两组均予以综合治疗,治疗组在此基础上加用布地奈德混悬液1mL(0.5mg)和硫酸特布他林雾化液1mL(2.5mg)联合雾化吸入,每天2次,观察两组的治愈率、总有效率、临床症状消失时间及平均住院天数。结果治疗组临床治愈率和总有效率明显优于对照组(P<0.05,0.01);临床症状消失时间、肺部啰音消失时间、平均住院时间明显优于对照组(P<0.05,0.01)。结论布地奈德与特布他林联合雾化吸入治疗毛细支气管炎安全有效。

作者曹亚民杨波

机构地区长沙市第四医院

出处《中国现代医生》 2009年第12期91-91,93,共2页 China Modern Doctor

关键词毛细支气管炎布地奈德特布他林雾化吸入

分类号 R562 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献8

1刘传合,张嘉林,沙莉,陈超,宋欣,朱汝南,赵林清,邓洁,王芳,康小惠,赵京,钱渊,陈育智.婴幼儿喘息与呼吸道病毒感染及过敏的关系[J].临床儿科杂志,2006,24(9):726-728. 被引量：27
2胡亚美江载芳主编.实用儿科学[M]：第7版[M].北京：人民卫生出版社,2002.1298-1299.
3张瑞珊,赵源,谭娴玲.普米克令舒吸入佐治小儿毛细支气管炎疗效观察[J].中国实用儿科杂志,2001,16(5):289-291. 被引量：252
4罗运春陈小芳.毛细支气管炎远期气道超声雾化蒸馏水激发试验,附23例报告.临床儿科杂志,2000,18(2):125-126.
5Weillver RC.Therapy for bronchinlitis;help wanted[J].J Pediatric,1997,130(2):170-172.
6Jan LL,Kimpen MD,Urs B,et al.Treatment of respiratory syncytial virus bronchiolitis:1995 poll of members of the European society for pediatric infections diseases[J].Pediatric Infection Disease,1997,16(5):478.
7李明华殷凯生董竟成.哮喘药物治疗学[M].北京:人民卫生出版社,2001.177.
8陈新谦，金有豫，汤光．新编药物学[M]．第15版．北京：人民卫生出版社，2004．90

二级参考文献13

1曹力,卢竞,钱渊,陈慧中,朱汝南,邓洁,王芳,王天有,曹玲,袁艺,牟京辉,朱春梅.6岁以下儿童急性下呼吸道感染的病毒病原及临床研究[J].中国实用儿科杂志,2004,19(9):528-531. 被引量：37
2Ills S, yon Mutius E, Lau S, et al. Early children infectious diseases and the development of asthma up to school age:a birth cohort study. BMJ, 2001,322 (7283) : 390-395.
3Roman M, Calhoun WJ, Hinton KL, et al. Respiratory syncytial virus infection in infants is associated with predominant Th2 - like response. Am J Respir Crit Care Med, 1997,156( 1 ) : 190-195.
4Pala P,Bjarnason R,Sigurbergsson,et al. Enhanced IL-4 response in children with a history of respiratory syncytial virus bronchiolitis in infancy. Eur Respir J ,2002,20(2) :376-382.
5Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics, 2002,109 (2) : 362-367.
6Sigurs N ,Gustafsson PM, Bjamason R ,et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and alergy at age 13. Am J Respir Crit Care Med,2005,171 (2):137- 141.
7Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by aeg 13 years. Lancet, 1999,354 (9178 ) : 541-545.
8Barends M,van Oosten M,de Rond CGH,et al. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation. J Infect Dis, 2004,189(10) : 1866-1872.
9Juntti H, Kokkonen J, Dunder T,et al. Association of an early respiratory virus infection and atopic allergy. Allergy,2003,58 (9) : 878-884.
10Kotaniemi-Syrjanen A,Reijonen TM,Korhonen K,et al.Wheezing requiring hospitalization in early childhood: predictive factors for asthma in a six- year follow-up. Pediatr Allergy Immunol,2002,13(6) :418-425.